As manufacturing, testing,&delivery

Ended Definitive Contract Awarded Last action

Contract number
W81XWH17C0004
Awardee
Awarding agency
Obligated
$6,305,037

Award facts

Opportunity
Contract value 100% obligated
$6,305,036.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00012 $0
Change Order P00011 · Manufacture of ivas & PBS for FDA licensure. $0
Change Order P00010 · Action: changes to the ivas stability testing program and manufacturing, and administrative changes. Requirement: manufacture of ivas & PBS for FDA licensure. -$50,926
Exercise an Option P00009 · Requirement: manufacture of ivas and PBS for FDA licensure. Action: exercise option clin 0009. $137,261
Supplemental Agreement for work within scope P00008 · Requirement: manufacture of ivas & PBS for FDA licensure. Action: manufacture of ivas & PBS registration batches and stability testing. $901,775
Other Administrative Action P00007 $513,430
Exercise an Option P00006 $311,227
Supplemental Agreement for work within scope P00005 · Requirement: manufacturing, testing, labeling, and delivery of intravenous artesunate and phosphate buffer solution diluent. Action: additional aseptic… $137,261
Supplemental Agreement for work within scope P00004 · Manufacturing, testing, labeling, and delivery of intravenous artesunate (ivas) and phosphate buffer solution (PBS) diluent $1,064,795
Supplemental Agreement for work within scope P00003 $6,259
Supplemental Agreement for work within scope P00002 $135,634
Supplemental Agreement for work within scope P00001 · Ivas MFG., testing, labeling,&delivery $521,507
Original award $2,626,814
Show all 13

About this award

Written by GovTribe AI ·

Dalton Chemical Laboratories Inc., doing business as Dalton Pharma Services, has been awarded a definitive contract valued at approximately $6.3 million by the Department of the Army Medical Command. The firm fixed price contract is for the manufacturing, testing, and delivery of unspecified products or services with performance at Dalton's facility in Ottawa, Ontario, Canada. No set-aside designation was applied to the original solicitation. Dalton will serve as the prime contractor on the contract, which has a period of performance through March 2023 and was awarded in November 2016 to support the Medical Command's medical research and development programs.

Quick answers

Who was awarded contract W81XWH17C0004?

W81XWH17C0004 was awarded to Dalton Chemical Laboratories Inc. by Medical Command (Department of the Army) on November 7, 2016.

How much is contract W81XWH17C0004 worth?

The government has obligated $6,305,037 on W81XWH17C0004.

Was contract W81XWH17C0004 competed?

The extent of competition for W81XWH17C0004 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login